In partnership with

  • Conferences
  • Disease Areas
  • News
  • Articles
  • Contact
    • twitter
    Highlights from

    ACC 2020

    Together with World Congress of Cardiology

    Virtual 28 - 30 March 2020

    Articles

    Letter from the Editor

    article thumbnail

    Letter from the Editor

    Heart Failure and Cardiomyopathies

    Vericiguat shows beneficial effects in a very high-risk HF population

    Mavacamten shows promising results in non-obstructive hypertrophic cardiomyopathy

    No role for sodium nitrite in out-of-hospital cardiac arrest

    Vascular Medicine and Thromboembolism

    Rivaroxaban and aspirin effective and safe for PAD patients

    Subgroup analysis VOYAGER PAD

    TAILOR-PCI misses endpoint but still provides valuable insights

    Edoxaban: alternative to warfarin after surgical aortic or mitral valve procedures?

    Bleeding reduction post-TAVI with OAC alone vs OAC + clopidogrel

    Apixaban offers new perspective for cancer patients in need of anticoagulation

    Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery

    Interventional Cardiology

    TAVR safe and effective in low-risk bicuspid aortic stenosis patients

    TAVR model reveals differences in hospital outcomes

    TAVR versus surgery in older patients

    Real-world evidence for MitraClip

    2-year results show non-significant outcomes TAVR vs surgery in severe aortic stenosis

    Renal denervation better than sham for blood pressure

    Radial artery best for second bypass

    PCI and CABG are equal in left main CAD

    Infusion of ethanol in the vein of Marshall for persistent AF

    Atrial Fibrillation/Acute Coronary Syndrome

    Fewer adverse events with ticagrelor monotherapy after 3 months DAPT

    TWILIGHT sub-study: same outcomes for diabetes patients

    TWILIGHT sub-study: complex PCI patients

    LAAO Watchman registry data positive

    Apixaban in AF patients with recent ACS/PCI: Drop aspirin after 30 days

    Genetics and Prevention

    Homozygous FH responds to alirocumab

    Evinacumab significantly reduces LDL-C in homozygous FH patients

    Higher serum levels of eicosapentaenoic acid correlate with reduced CV events

    Quit smoking: vaping + counselling helps

    Top image: @ iStockPhoto: MStudioImages

    The content and interpretation of these conference highlights are the views and comments of the speakers/ authors.

    BACK TO TOP